Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas

<p>Abstract</p> <p>Background</p> <p>Both mechanistic features and recent correlative findings suggest a potential role for protein kinase C-beta (PKC-β) in tumor pathogenesis, particularly in B-cell malignancies. To evaluate the role of this gene in lymphoid malignanci...

Full description

Bibliographic Details
Main Authors: Lin Boris K, Sutton Susan, Brail Leslie, Lahn Michael, Phong Mark, Li Shuyu, Thornton Donald, Liao Birong
Format: Article
Language:English
Published: BMC 2007-02-01
Series:Biology Direct
Online Access:http://www.biology-direct.com/content/2/1/8
_version_ 1818353727489179648
author Lin Boris K
Sutton Susan
Brail Leslie
Lahn Michael
Phong Mark
Li Shuyu
Thornton Donald
Liao Birong
author_facet Lin Boris K
Sutton Susan
Brail Leslie
Lahn Michael
Phong Mark
Li Shuyu
Thornton Donald
Liao Birong
author_sort Lin Boris K
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Both mechanistic features and recent correlative findings suggest a potential role for protein kinase C-beta (PKC-β) in tumor pathogenesis, particularly in B-cell malignancies. To evaluate the role of this gene in lymphoid malignancies, we analyzed global gene expression data to quantify PKC-β expression across diagnostic groups and, when possible, determined correlations between PKC-β expression and survival.</p> <p>Results</p> <p>Our analysis showed that the level of PKC-β expression was highest in chronic lymphocytic leukemia and follicular lymphoma. Within diffuse large-B cell lymphoma (DLBCL), PKC-β expression was significantly higher in activated B-cell- like subtype than germinal center B-cell- like subtype (<it>P </it>< 0.0001). Elevated PKC-β appeared to be associated with worse survival in both of these subtypes. When analyzed within clinically defined risk groups established by the International Prognostic Index (IPI), PKC-β expression was lowest in patients with low IPI scores (0–1). Within intermediate- and high-risk IPI groups, elevated PKC-β expression was associated with worse survival, suggesting that PKC-β may expand the prognostic value of the IPI. Results of global gene expression analyses of DLBCL samples corroborate previous observations that anti-apoptosis, cell proliferation, and B-cell proliferation signaling pathways are functionally related to PKC-β.</p> <p>Conclusion</p> <p>We present a first detailed pharmacogenomics report comparing PKC-β mRNA expression across different lymphoid malignancies and evaluating it as an outcome predictor. Our findings suggest that DLBCL patients with elevated PKC-β have a worse prognosis, indicating that further evaluation of PKC-β as a chemotherapeutic target for lymphoid malignancies is warranted.</p> <p>Reviewers</p> <p>This article was reviewed by Dr. Pierre Pontarotti, Dr. Kateryna Makova, and Dr. Matthew Coleman (nominated by Dr. Sandrine Dudoit).</p>
first_indexed 2024-12-13T19:14:08Z
format Article
id doaj.art-d40c5f7b40f74918b42342595baeea27
institution Directory Open Access Journal
issn 1745-6150
language English
last_indexed 2024-12-13T19:14:08Z
publishDate 2007-02-01
publisher BMC
record_format Article
series Biology Direct
spelling doaj.art-d40c5f7b40f74918b42342595baeea272022-12-21T23:34:21ZengBMCBiology Direct1745-61502007-02-0121810.1186/1745-6150-2-8Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomasLin Boris KSutton SusanBrail LeslieLahn MichaelPhong MarkLi ShuyuThornton DonaldLiao Birong<p>Abstract</p> <p>Background</p> <p>Both mechanistic features and recent correlative findings suggest a potential role for protein kinase C-beta (PKC-β) in tumor pathogenesis, particularly in B-cell malignancies. To evaluate the role of this gene in lymphoid malignancies, we analyzed global gene expression data to quantify PKC-β expression across diagnostic groups and, when possible, determined correlations between PKC-β expression and survival.</p> <p>Results</p> <p>Our analysis showed that the level of PKC-β expression was highest in chronic lymphocytic leukemia and follicular lymphoma. Within diffuse large-B cell lymphoma (DLBCL), PKC-β expression was significantly higher in activated B-cell- like subtype than germinal center B-cell- like subtype (<it>P </it>< 0.0001). Elevated PKC-β appeared to be associated with worse survival in both of these subtypes. When analyzed within clinically defined risk groups established by the International Prognostic Index (IPI), PKC-β expression was lowest in patients with low IPI scores (0–1). Within intermediate- and high-risk IPI groups, elevated PKC-β expression was associated with worse survival, suggesting that PKC-β may expand the prognostic value of the IPI. Results of global gene expression analyses of DLBCL samples corroborate previous observations that anti-apoptosis, cell proliferation, and B-cell proliferation signaling pathways are functionally related to PKC-β.</p> <p>Conclusion</p> <p>We present a first detailed pharmacogenomics report comparing PKC-β mRNA expression across different lymphoid malignancies and evaluating it as an outcome predictor. Our findings suggest that DLBCL patients with elevated PKC-β have a worse prognosis, indicating that further evaluation of PKC-β as a chemotherapeutic target for lymphoid malignancies is warranted.</p> <p>Reviewers</p> <p>This article was reviewed by Dr. Pierre Pontarotti, Dr. Kateryna Makova, and Dr. Matthew Coleman (nominated by Dr. Sandrine Dudoit).</p>http://www.biology-direct.com/content/2/1/8
spellingShingle Lin Boris K
Sutton Susan
Brail Leslie
Lahn Michael
Phong Mark
Li Shuyu
Thornton Donald
Liao Birong
Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas
Biology Direct
title Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas
title_full Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas
title_fullStr Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas
title_full_unstemmed Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas
title_short Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas
title_sort retrospective analysis of protein kinase c beta pkc β expression in lymphoid malignancies and its association with survival in diffuse large b cell lymphomas
url http://www.biology-direct.com/content/2/1/8
work_keys_str_mv AT linborisk retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas
AT suttonsusan retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas
AT brailleslie retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas
AT lahnmichael retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas
AT phongmark retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas
AT lishuyu retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas
AT thorntondonald retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas
AT liaobirong retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas